Micrurus snake venoms activate human complement system and generate anaphylatoxins. 2012

Gabriela D Tanaka, and Giselle Pidde-Queiroz, and Maria de Fátima D Furtado, and Carmen van den Berg, and Denise V Tambourgi
Immunochemistry Laboratory, Butantan Institute, Av, Vital Brazil, 1500, São Paulo, 05503-900, Brazil.

BACKGROUND The genus Micrurus, coral snakes (Serpentes, Elapidae), comprises more than 120 species and subspecies distributed from the south United States to the south of South America. Micrurus snake bites can cause death by muscle paralysis and further respiratory arrest within a few hours after envenomation. Clinical observations show mainly neurotoxic symptoms, although other biological activities have also been experimentally observed, including cardiotoxicity, hemolysis, edema and myotoxicity. RESULTS In the present study we have investigated the action of venoms from seven species of snakes from the genus Micrurus on the complement system in in vitro studies. Several of the Micrurus species could consume the classical and/or the lectin pathways, but not the alternative pathway, and C3a, C4a and C5a were generated in sera treated with the venoms as result of this complement activation. Micrurus venoms were also able to directly cleave the α chain of the component C3, but not of the C4, which was inhibited by 1,10 Phenanthroline, suggesting the presence of a C3α chain specific metalloprotease in Micrurus spp venoms. Furthermore, complement activation was in part associated with the cleavage of C1-Inhibitor by protease(s) present in the venoms, which disrupts complement activation control. CONCLUSIONS Micrurus venoms can activate the complement system, generating a significant amount of anaphylatoxins, which may assist due to their vasodilatory effects, to enhance the spreading of other venom components during the envenomation process.

UI MeSH Term Description Entries
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D004546 Elapid Venoms Venoms from snakes of the family Elapidae, including cobras, kraits, mambas, coral, tiger, and Australian snakes. The venoms contain polypeptide toxins of various kinds, cytolytic, hemolytic, and neurotoxic factors, but fewer enzymes than viper or crotalid venoms. Many of the toxins have been characterized. Cobra Venoms,Elapidae Venom,Elapidae Venoms,Naja Venoms,Cobra Venom,Elapid Venom,Hydrophid Venom,Hydrophid Venoms,King Cobra Venom,Naja Venom,Ophiophagus hannah Venom,Sea Snake Venom,Sea Snake Venoms,Venom, Cobra,Venom, Elapid,Venom, Elapidae,Venom, Hydrophid,Venom, King Cobra,Venom, Naja,Venom, Ophiophagus hannah,Venom, Sea Snake,Venoms, Cobra,Venoms, Elapid,Venoms, Elapidae,Venoms, Hydrophid,Venoms, Naja,Venoms, Sea Snake
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000706 Anaphylatoxins Serum peptides derived from certain cleaved COMPLEMENT PROTEINS during COMPLEMENT ACTIVATION. They induce smooth MUSCLE CONTRACTION; mast cell HISTAMINE RELEASE; PLATELET AGGREGATION; and act as mediators of the local inflammatory process. The order of anaphylatoxin activity from the strongest to the weakest is C5a, C3a, C4a, and C5a des-arginine. Anaphylatoxin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D050718 Complement C1 Inhibitor Protein An endogenous 105-kDa plasma glycoprotein produced primarily by the LIVER and MONOCYTES. It inhibits a broad spectrum of proteases, including the COMPLEMENT C1R and the COMPLEMENT C1S proteases of the CLASSICAL COMPLEMENT PATHWAY, and the MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES. C1-INH-deficient individuals suffer from HEREDITARY ANGIOEDEMA TYPES I AND II. C1 Esterase Inhibitor,C1-INH Protein,C1-Inhibitor Protein,Complement C1-Inhibitor Protein,Plasma Protease C1 Inhibitor,SERPING1,Serpin Family G Member 1,Serpin G1,C1 INH Protein,C1 Inhibitor Protein,Esterase Inhibitor, C1
D059748 Proteolysis Cleavage of proteins into smaller peptides or amino acids either by PROTEASES or non-enzymatically (e.g., Hydrolysis). It does not include Protein Processing, Post-Translational. Protein Degradation,Protein Digestion,Degradation, Protein,Degradations, Protein,Digestion, Protein,Digestions, Protein,Protein Degradations,Protein Digestions,Proteolyses
D017815 Elapidae A family of extremely venomous snakes which include coral snakes, cobras and sea snakes. They are widely distributed, occurring in the Southern United States, South America, Africa, Southern Asia, Australia, and the Pacific Islands. Like viperids (VIPERIDAE), they have fangs in the front part of the upper jaw which discharge venom that is neurotoxic. Acanthophiinae,Notechis,Pseudonaja,Cobra,Elapid Snakes,Elapids,Cobras,Elapid,Elapid Snake,Snake, Elapid

Related Publications

Gabriela D Tanaka, and Giselle Pidde-Queiroz, and Maria de Fátima D Furtado, and Carmen van den Berg, and Denise V Tambourgi
June 1994, Toxicon : official journal of the International Society on Toxinology,
Gabriela D Tanaka, and Giselle Pidde-Queiroz, and Maria de Fátima D Furtado, and Carmen van den Berg, and Denise V Tambourgi
January 1991, Comparative biochemistry and physiology. B, Comparative biochemistry,
Gabriela D Tanaka, and Giselle Pidde-Queiroz, and Maria de Fátima D Furtado, and Carmen van den Berg, and Denise V Tambourgi
January 1991, Comparative biochemistry and physiology. B, Comparative biochemistry,
Gabriela D Tanaka, and Giselle Pidde-Queiroz, and Maria de Fátima D Furtado, and Carmen van den Berg, and Denise V Tambourgi
January 2005, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology,
Gabriela D Tanaka, and Giselle Pidde-Queiroz, and Maria de Fátima D Furtado, and Carmen van den Berg, and Denise V Tambourgi
December 2010, Artificial organs,
Gabriela D Tanaka, and Giselle Pidde-Queiroz, and Maria de Fátima D Furtado, and Carmen van den Berg, and Denise V Tambourgi
October 2010, Molecular immunology,
Gabriela D Tanaka, and Giselle Pidde-Queiroz, and Maria de Fátima D Furtado, and Carmen van den Berg, and Denise V Tambourgi
June 2017, Biochimie,
Gabriela D Tanaka, and Giselle Pidde-Queiroz, and Maria de Fátima D Furtado, and Carmen van den Berg, and Denise V Tambourgi
July 2001, Toxicon : official journal of the International Society on Toxinology,
Gabriela D Tanaka, and Giselle Pidde-Queiroz, and Maria de Fátima D Furtado, and Carmen van den Berg, and Denise V Tambourgi
December 1998, Toxicon : official journal of the International Society on Toxinology,
Gabriela D Tanaka, and Giselle Pidde-Queiroz, and Maria de Fátima D Furtado, and Carmen van den Berg, and Denise V Tambourgi
December 2019, Toxicon : official journal of the International Society on Toxinology,
Copied contents to your clipboard!